Veronica Yumiceba

Ms. Veronica Yumiceba

Universität zu Lübeck, Germany
orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
25 June 2019 in Scientific Reports
Verified
Journal Article
Open access
PDF file
AZAna Karina Zambrano
Ana Karina Zambrano
AGAníbal Gaviria
Aníbal Gaviria
SCSantiago Cobos-Navarrete
Santiago Cobos-Navarrete
CGCarmen Gruezo
Carmen Gruezo
CRCristina Jeanneth Rodríguez-Pólit
Cristina Jeanneth Rodríguez-Pólit
CPCesar Paz-y-Mino
Cesar Paz-y-Mino
The history of Ecuador was marked by the arrival of Europeans with Africans, resulting in the mixture of Native Americans with Africans and Europeans. The present study contributes to the knowledge of the Ecuadorian mestizo population by offering information about ancestry and ethnic heterogeneity. Forty-six AIM-InDels (Ancestry Informative Insertion/Deletion Markers) were used to obtain information on 240 Ecuadorian individuals from three regions (Amazonia, the Highlands, and the Coast). As a result, the population involved a significant contribution from Native Americans (values up to 51%), followed by Europeans (values up to 33%) and Africans (values up to 13%). Furthermore, we compared the data obtained with nine previously reported scientific articles on autosomal, mitochondrial DNA and Y chromosomes. The admixture results correspond to Ecuador’s historical background and vary slightly between regions.

7 August 2019 in Frontiers in Molecular Biosciences
Verified
Journal Article
Open access
JGJennyfer M García-Cárdenas
Jennyfer M García-Cárdenas
SGSantiago Guerrero
Santiago Guerrero
Andrés López-CortésAndrés López-Cortés
Andrés López-Cortés
Isaac Armendáriz-CastilloIsaac Armendáriz-Castillo
Isaac Armendáriz-Castillo
PGPatricia Guevara-Ramírez
Patricia Guevara-Ramírez
CPCesar Paz-y-Mino
Cesar Paz-y-Mino
Colorectal cancer (CRC) is a major health problem with an estimated 1. 8 million new cases worldwide. To date, most CRC studies have focused on DNA-related aberrations, leaving post-transcriptional processes under-studied. However, post-transcriptional alterations have been shown to play a significant part in the maintenance of cancer features. RNA binding proteins (RBPs) are uprising as critical regulators of every cancer hallmark, yet little is known regarding the underlying mechanisms and key downstream oncogenic targets. Currently, more than a thousand RBPs have been discovered in humans and only a few have been implicated in the carcinogenic process and even much less in CRC. Identification of cancer-related RBPs is of great interest to better understand CRC biology and potentially unveil new targets for cancer therapy and prognostic biomarkers. In this work, we reviewed all RBPs which have a role in CRC, including their control by microRNAs, xenograft studies and their clinical implications.

23 December 2019 in BioMed Research International
Verified
Journal Article
Open access
PDF file
Isaac Armendáriz-CastilloIsaac Armendáriz-Castillo
Isaac Armendáriz-Castillo
SGSantiago Guerrero
Santiago Guerrero
AVAntonella Vera-Guapi
Antonella Vera-Guapi
TCTiffany Cevallos-Vilatuña
Tiffany Cevallos-Vilatuña
JGJennyfer M García-Cárdenas
Jennyfer M García-Cárdenas
CPCesar Paz-y-Mino
Cesar Paz-y-Mino
Background. Many studies, comparing the health associated risks of electronic cigarettes with conventional cigarettes focus mainly on the common chemical compounds found between them. Aim. Review chemical compounds found exclusively in electronic cigarettes and describe their toxic effects, focusing on electronic-cigarette-only and dual electronic-cigarette and conventional cigarette users. Data Sources. Literature search was carried out using PubMed. Study Eligibility Criteria. Articles related exclusively to conventional and electronic cigarettes’ chemical composition. Articles which reported to be financed from tobacco or electronic cigarettes industries, not reporting source of funding, not related to the chemical composition of electronic and conventional cigarettes and not relevant to tobacco research were excluded. Methods and Results. Chemical compounds reported in the selected studies were tabulated using the Chemical Abstracts Service registry number for chemical substances information. A total of 50 chemical compounds were exclusively reported to be present in electronic cigarettes. Crucial health risks identified were: eye, skin, and respiratory tract irritation, with almost 50% of incidence, an increment of 10% in cytotoxic effects, when compared to compounds in common with conventional cigarettes and around 11% of compounds with unknown effects to human health. Limitations. Articles reporting conflicts of interest. Conclusions and Implications of Key Findings. Despite being considered as less harmful for human health, compounds found in electronic cigarettes are still a matter of research and their effects on health are yet unknown. The use of these devices is not recommended for first time users and it is considered hazardous for dual users.

9 September 2022 in Journal of Medical Genetics
Verified
Journal Article
Open access
PDF file
JMJakob A Meinel
Jakob A Meinel
VYVeronica Yumiceba
Veronica Yumiceba
AKAxel Künstner
Axel Künstner
KSKristin Schultz
Kristin Schultz
NKNathalie Kruse
Nathalie Kruse
RWRalf Werner
Ralf Werner
Background: Duplications at the Xp21.2 locus have previously been linked to 46,XY gonadal dysgenesis (GD), which is thought to result from gene dosage effects of NR0B1 (DAX1), but the exact disease mechanism remains unknown. Methods: Patients with 46,XY GD were analysed by whole genome sequencing. Identified structural variants were confirmed by array CGH and analysed by high-throughput chromosome conformation capture (Hi-C). Results: We identified two unrelated patients: one showing a complex rearrangement upstream of NR0B1 and a second harbouring a 1.2 Mb triplication, including NR0B1. Whole genome sequencing and Hi-C analysis revealed the rewiring of a topological-associated domain (TAD) boundary close to NR0B1 associated with neo-TAD formation and may cause enhancer hijacking and ectopic NR0B1 expression. Modelling of previous Xp21.2 structural variations associated with isolated GD support our hypothesis and predict similar neo-TAD formation as well as TAD fusion. Conclusion: Here we present a general mechanism how deletions, duplications or inversions at the NR0B1 locus can lead to partial or complete GD by disrupting the cognate TAD in the vicinity of NR0B1. This model not only allows better diagnosis of GD with copy number variations (CNVs) at Xp21.2, but also gives deeper insight on how spatiotemporal activation of developmental genes can be disrupted by reorganised TADs causing impairment of gonadal development.

21 November 2022 in Leukemia
Verified
Journal Article
Open access
PDF file
SSSophie Steinhäuser
Sophie Steinhäuser
PSPatricia Silva
Patricia Silva
LLLennart Lenk
Lennart Lenk
TBThomas Beder
Thomas Beder
AHAlina Hartmann
Alina Hartmann
CBClaudia Dorothea Baldus
Claudia Dorothea Baldus
Acute myeloid leukemia (AML) is characterized by complex molecular alterations and driver mutations. Elderly patients show increased frequencies of IDH mutations with high chemoresistance and relapse rates despite recent therapeutic advances. Besides being associated with global promoter hypermethylation, IDH1 mutation facilitated changes in 3D DNA-conformation by CTCF-anchor methylation and upregulated oncogene expression in glioma, correlating with poor prognosis. Here, we investigated the role of IDH1 p.R132H mutation in altering 3D DNA-architecture and subsequent oncogene activation in AML. Using public RNA-Seq data, we identified upregulation of tyrosine kinase PDGFRA in IDH1-mutant patients, correlating with poor prognosis. DNA methylation analysis identified CpG hypermethylation within a CTCF-anchor upstream of PDGFRA in IDH1-mutant patients. Increased PDGFRA expression, PDGFRA-CTCF methylation and decreased CTCF binding were confirmed in AML CRISPR cells with heterozygous IDH1 p.R132H mutation and upon exogenous 2-HG treatment. IDH1-mutant cells showed higher sensitivity to tyrosine kinase inhibitor dasatinib, which was supported by reduced blast count in a patient with refractory IDH1-mutant AML after dasatinib treatment. Our data illustrate that IDH1 p.R132H mutation leads to CTCF hypermethylation, disrupting DNA-looping and insulation of PDGFRA, resulting in PDGFRA upregulation in IDH1-mutant AML. Treatment with dasatinib may offer a novel treatment strategy for IDH1-mutant AML.

9 May 2019 in PLOS Computational Biology
Verified
Journal Article
Open access
PDF file
SGSantiago Guerrero
Santiago Guerrero
Andrés López-CortésAndrés López-Cortés
Andrés López-Cortés
JGJennyfer M García-Cárdenas
Jennyfer M García-Cárdenas
PSPablo Saa
Pablo Saa
AIAlberto Indacochea
Alberto Indacochea
CPCesar Paz-y-Mino
Cesar Paz-y-Mino
Scientific data recording and reporting systems are of a great interest for endorsing reproducibility and transparency practices among the scientific community. Current research generates large datasets that can no longer be documented using paper lab notebooks (PLNs). In this regard, electronic laboratory notebooks (ELNs) could be a promising solution to replace PLNs and promote scientific reproducibility and transparency. We previously analyzed five ELNs and performed two survey-based studies to implement an ELN in a biomedical research institute. Among the ELNs tested, we found that Microsoft OneNote presents numerous features related to ELN best functionalities. In addition, both surveyed groups preferred OneNote over a scientifically designed ELN (PerkinElmer Elements). However, OneNote remains a general note-taking application and has not been designed for scientific purposes. We therefore provide a quick guide to adapt OneNote to an ELN workflow that can also be adjusted to other nonscientific ELNs.